Grant Downes is a 2020-2024 Self Graduate Fellow pursuing a Ph.D. in bioengineering at the University of Kansas. His current research lies in the development of an antigen-specific immunotherapy for safe and efficacious treatment of type 1 diabetes.
He is a former member of the KU track and field team, competing in the decathlon.